Skip to content

Mitchell Kronenberg

  • PhD
  • President and Chief Scientific Officer
  • La Jolla Institute for Allergy and Immunology
  • 5h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 176CitationsNumber of citations received by Mitchell's publications. Updated daily.

Publications (5)

  • LIG HT-HVEM signaling in keratinocytes controls development of dermatitis

    • Herro R
    • Shui J
    • Zahner S
    • et al.
    N/AReaders
    0Citations
    Get full text
  • CD1d-restricted peripheral T cell lymphoma in mice and humans

    • Bachy E
    • Urb M
    • Chandra S
    • et al.
    N/AReaders
    3Citations
    Get full text
  • Lipid and carbohydrate modifications of α-galactosylceramide differently influence mouse and human type I natural killer T cell activation

    • Birkholz A
    • Nemčovič M
    • Yu E
    • et al.
    N/AReaders
    5Citations
    Get full text
  • Erratum to The identification of the endogenous ligands of natural killer T cells reveals the presence of mammalian α-linked glycosylceramides [Immunity 41, (2014), 543-554]

    • Kain L
    • Webb B
    • Anderson B
    • et al.
    N/AReaders
    2Citations
    Get full text
  • Transcriptional reprogramming of mature CD4 + helper T cells generates distinct MHC class II-restricted cytotoxic T lymphocytes

    • Mucida D
    • Husain M
    • Muroi S
    • et al.
    N/AReaders
    106Citations
    Get full text

Professional experience

President and Chief Scientific Officer

La Jolla Institute for Allergy and Immunology

January 2003 - Present